Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

FGF23 induces left ventricular hypertrophy
Christian Faul, … , Martin G. Keane, Myles Wolf
Christian Faul, … , Martin G. Keane, Myles Wolf
Published October 10, 2011
Citation Information: J Clin Invest. 2011;121(11):4393-4408. https://doi.org/10.1172/JCI46122.
View: Text | PDF
Research Article Nephrology Article has an altmetric score of 31

FGF23 induces left ventricular hypertrophy

  • Text
  • PDF
Abstract

Chronic kidney disease (CKD) is a public health epidemic that increases risk of death due to cardiovascular disease. Left ventricular hypertrophy (LVH) is an important mechanism of cardiovascular disease in individuals with CKD. Elevated levels of FGF23 have been linked to greater risks of LVH and mortality in patients with CKD, but whether these risks represent causal effects of FGF23 is unknown. Here, we report that elevated FGF23 levels are independently associated with LVH in a large, racially diverse CKD cohort. FGF23 caused pathological hypertrophy of isolated rat cardiomyocytes via FGF receptor–dependent activation of the calcineurin-NFAT signaling pathway, but this effect was independent of klotho, the coreceptor for FGF23 in the kidney and parathyroid glands. Intramyocardial or intravenous injection of FGF23 in wild-type mice resulted in LVH, and klotho-deficient mice demonstrated elevated FGF23 levels and LVH. In an established animal model of CKD, treatment with an FGF–receptor blocker attenuated LVH, although no change in blood pressure was observed. These results unveil a klotho-independent, causal role for FGF23 in the pathogenesis of LVH and suggest that chronically elevated FGF23 levels contribute directly to high rates of LVH and mortality in individuals with CKD.

Authors

Christian Faul, Ansel P. Amaral, Behzad Oskouei, Ming-Chang Hu, Alexis Sloan, Tamara Isakova, Orlando M. Gutiérrez, Robier Aguillon-Prada, Joy Lincoln, Joshua M. Hare, Peter Mundel, Azorides Morales, Julia Scialla, Michael Fischer, Elsayed Z. Soliman, Jing Chen, Alan S. Go, Sylvia E. Rosas, Lisa Nessel, Raymond R. Townsend, Harold I. Feldman, Martin St. John Sutton, Akinlolu Ojo, Crystal Gadegbeku, Giovana Seno Di Marco, Stefan Reuter, Dominik Kentrup, Klaus Tiemann, Marcus Brand, Joseph A. Hill, Orson W. Moe, Makoto Kuro-o, John W. Kusek, Martin G. Keane, Myles Wolf

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2009 Total
Citations: 20 58 74 87 93 69 85 83 76 66 72 91 84 43 1 1 1003
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2016 (66)

Title and authors Publication Year
FGF23 signaling impairs neutrophil recruitment and host defense during CKD
Jan Rossaint, Jessica Oehmichen, Hugo Van Aken, Stefan Reuter, Hermann Pavenstädt, Melanie Meersch, Mark Unruh, Alexander Zarbock
Journal of Clinical Investigation 2016
Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease
S Singh, A Grabner, C Yanucil, K Schramm, B Czaya, S Krick, MJ Czaja, R Bartz, R Abraham, GS di Marco, M Brand, M Wolf, C Faul
Kidney International 2016
Stop chronic kidney disease progression: Time is approaching
UA el Din, MM Salem, DO Abdulazim
World Journal of Nephrology 2016
Fibroblast Growth Factor 23 Levels Associate with AKI and Death in Critical Illness
DE Leaf, KA Jacob, A Srivastava, ME Chen, M Christov, H Jüppner, VS Sabbisetti, A Martin, M Wolf, SS Waikar
Journal of the American Society of Nephrology : JASN 2016
Fibroblast Growth Factor 23 and Cause-Specific Mortality in the General Population: The Northern Manhattan Study
N Souma, T Isakova, D Lipiszko, RL Sacco, MS Elkind, JT DeRosa, SJ Silverberg, AJ Mendez, C Dong, CB Wright, M Wolf
The Journal of clinical endocrinology and metabolism 2016
Inflammation regulates fibroblast growth factor 23 production:
C Francis, V David
Current Opinion in Nephrology and Hypertension 2016
FGF23 in kidney transplant: the strange case of Doctor Jekyll and Mister Hyde
G Cianciolo, M Cozzolino
Clinical Kidney Journal 2016
Cardiac actions of fibroblast growth factor 23
C Faul
Bone 2016
Fibroblast Growth Factor-23—A Potential Uremic Toxin
P Kuczera, M Adamczak, A Wiecek
Toxins 2016
Fibroblast growth factor 23: fueling the fire
M Hanudel, H Jüppner, IB Salusky
Kidney International 2016
Clinical features of CKD-MBD in Japan: cohort studies and registry
T Hamano, Y Sakaguchi, N Fujii, Y Isaka
Clinical and Experimental Nephrology 2016
Extrarenal effects of FGF23
D Haffner, M Leifheit-Nestler
Pediatric Nephrology 2016
Ironing out the cross talk between FGF23 and inflammation
V David, C Francis, JL Babitt
American journal of physiology. Renal physiology 2016
Roles of FGF Signals in Heart Development, Health, and Disease
N Itoh, H Ohta, Y Nakayama, M Konishi
Frontiers in Cell and Developmental Biology 2016
CKD-Mineral Bone Disorder in Stage 4 and 5 CKD: What We Know Today?
ML Melamed, RS Buttar, M Coco
Advances in Chronic Kidney Disease 2016
Fibroblast growth factor-23 and renin–angiotensin system levels in vitamin-D-dependent rickets type I
C Cuervo, CL Abitbol, GE Zilleruelo, M Freundlich
Pediatric Nephrology 2016
Vitamins & Hormones
JA Neyra, MC Hu
Vitamins & Hormones 2016
FGF23 from bench to bedside
CP Kovesdy, LD Quarles
American journal of physiology. Renal physiology 2016
Vascular calcification in CKD-MBD: Roles for phosphate, FGF23, and Klotho
S Yamada, CM Giachelli
Bone 2016
Effect of oral sodium bicarbonate on fibroblast growth factor-23 in patients with chronic kidney disease: a pilot study
W Chen, ML Melamed, TH Hostetter, C Bauer, AC Raff, AL Almudevar, A Lalonde, S Messing, MK Abramowitz
BMC Nephrology 2016
Use of serum fibroblast growth factor 23 vs. plasma B-type natriuretic peptide levels in assessing the pathophysiology of patients with heart failure
M Imazu, H Takahama, M Amaki, Y Sugano, T Ohara, T Hasegawa, H Kanzaki, T Anzai, N Mochizuki, H Asanuma, M Asakura, M Kitakaze
Hypertension Research 2016
The role of fibroblast growth factor 23 and Klotho in uremic cardiomyopathy:
A Grabner, C Faul
Current Opinion in Nephrology and Hypertension 2016
Genetic insights into the mechanisms of Fgf signaling
JR Brewer, P Mazot, P Soriano
Genes & development 2016
DNMT1 and HDAC2 Cooperate to Facilitate Aberrant Promoter Methylation in Inorganic Phosphate-Induced Endothelial-Mesenchymal Transition
X Tan, X Xu, M Zeisberg, EM Zeisberg, O El-Maarri
PloS one 2016
Klotho modulates FGF23-mediated NO synthesis and oxidative stress in human coronary artery endothelial cells
B Richter, J Haller, D Haffner, M Leifheit-Nestler
Pflügers Archiv - European Journal of Physiology 2016
Enhanced FGF23 production in mice expressing PI3K-insensitive GSK3 is normalized by β-blocker treatment
A Fajol, H Chen, AT Umbach, LD Quarles, F Lang, M Föller
The FASEB Journal 2016
Phosphate Toxicity in CKD: The Killer among Us
CS Ritter, E Slatopolsky
Clinical journal of the American Society of Nephrology : CJASN 2016
Nutrition in Cardioskeletal Health
KM Gallant, CM Weaver, DA Towler, SV Thuppal, RL Bailey
Advances in nutrition (Bethesda, Md.) 2016
Klotho/FGF23 Axis in Chronic Kidney Disease and Cardiovascular Disease
X Lu, MC Hu
Kidney Diseases 2016
Bidirectional Translation in Cardiovascular Calcification
CS Hilaire, M Liberman, JD Miller
Arteriosclerosis, thrombosis, and vascular biology 2016
Fibroblast Growth Factor-23 and Frailty in Elderly Community-Dwelling Individuals: The Cardiovascular Health Study
T Beben, JH Ix, MG Shlipak, MJ Sarnak, LF Fried, AN Hoofnagle, M Chonchol, BR Kestenbaum, IH de Boer, DE Rifkin
Journal of the American Geriatrics Society 2016
Design and rationale of a multicentre, randomised, double-blind, placebo-controlled clinical trial to evaluate the effect of vitamin D on ventricular remodelling in patients with anterior myocardial infarction: the VITamin D in Acute Myocardial Infarction (VITDAMI) trial
J Tuñón, I González-Hernández, L Llanos-Jiménez, J Alonso-Martín, JM Escudier-Villa, N Tarín, C Cristóbal, P Sanz, AM Pello, Á Aceña, R Carda, M Orejas, M Tomás, P Beltrán, MC Rueda, E Marcos, JM Serrano-Antolín, C Gutiérrez-Landaluce, R Jiménez, J Cabezudo, A Curcio, G Peces-Barba, E González-Parra, R Muñoz-Siscart, ML González-Casaus, A Lorenzo, A Huelmos, J Goicolea, B Ibáñez, G Hernández, LM Alonso-Pulpón, J Farré, Ó Lorenzo, I Mahíllo-Fernández, J Egido
BMJ Open 2016
Skeletal Muscle, but not Cardiovascular Function, Is Altered in a Mouse Model of Autosomal Recessive Hypophosphatemic Rickets
MJ Wacker, CD Touchberry, N Silswal, L Brotto, CJ Elmore, LF Bonewald, J Andresen, M Brotto
Frontiers in physiology 2016
Calcium as a cardiovascular toxin in CKD-MBD
SM Moe
Bone 2016
The Kidney-Vascular-Bone Axis in the Chronic Kidney Disease-Mineral Bone Disorder:
ME Seifert, KA Hruska
Transplantation 2016
Fibroblast growth factor 23 levels are elevated and associated with severe acute kidney injury and death following cardiac surgery
DE Leaf, M Christov, H Jüppner, E Siew, TA Ikizler, A Bian, G Chen, VS Sabbisetti, JV Bonventre, X Cai, M Wolf, SS Waikar
Kidney International 2016
Counter-regulatory paracrine actions of FGF-23 and 1,25(OH) 2 D in macrophages
X Han, L Li, J Yang, G King, Z Xiao, LD Quarles, W Ellmeier
FEBS Letters 2016
Plasma Levels of Monocyte Chemoattractant Protein-1, n-Terminal Fragment of Brain Natriuretic Peptide and Calcidiol Are Independently Associated with the Complexity of Coronary Artery Disease
R Martín-Reyes, JA Franco-Peláez, Ó Lorenzo, ML González-Casaus, AM Pello, Á Aceña, R Carda, JL Martín-Ventura, L Blanco-Colio, ML Martín-Mariscal, J Martínez-Milla, R Villa-Bellosta, A Piñero, F Navarro, J Egido, J Tuñón, J Devaney
PloS one 2016
Deleterious effects of phosphate on vascular and endothelial function via disruption to the nitric oxide pathway
KK Stevens, L Denby, RK Patel, PB Mark, S Kettlewell, GL Smith, MJ Clancy, C Delles, AG Jardine
Nephrology Dialysis Transplantation 2016
Markers of kidney disease and risk of subclinical and clinical heart failure in African Americans: the Jackson Heart Study
N Bansal, R Katz, J Himmelfarb, M Afkarian, B Kestenbaum, IH de Boer, B Young
Nephrology Dialysis Transplantation 2016
Fibroblast growth factor-23 and chronic allograft injury in pediatric renal transplant recipients: a Midwest Pediatric Nephrology Consortium study
ME Seifert, IF Ashoor, ML Chiang, AS Chishti, DJ Dietzen, DS Gipson, HS Janjua, DT Selewski, KA Hruska
Pediatric Transplantation 2016
Soluble Guanylate Cyclase Stimulators: a Novel Treatment Option for Heart Failure Associated with Cardiorenal Syndromes?
RF Dubin, SJ Shah
Current Heart Failure Reports 2016
A Prospective Cohort Study of Mineral Metabolism After Kidney Transplantation:
M Wolf, MR Weir, N Kopyt, RB Mannon, JV Visger, H Deng, S Yue, F Vincenti
Transplantation 2016
Mineral and Bone Disorder and Its Association with Cardiovascular Parameters in Chinese Patients with Chronic Kidney Disease
C Zhou, F Wang, JW Wang, LX Zhang, MH Zhao
Chinese Medical Journal 2016
Fibroblast Growth Factor 23 and Risk of CKD Progression in Children
AA Portale, MS Wolf, S Messinger, F Perwad, H Ju ppner, BA Warady, SL Furth, IB Salusky
Clinical journal of the American Society of Nephrology : CJASN 2016
Silent Cerebral Microbleeds and Longitudinal Risk of Renal and Cardiovascular Events in Patients with CKD
H Shima, T Mori, M Ooi, M Sonoda, T Shoji, E Ishimura, M Okamura, N Ishizaka, M Inaba
Clinical journal of the American Society of Nephrology : CJASN 2016
FGF23 in chronic kidney disease: are we lost in translation?
J Bacchetta
BoneKEy Reports 2016
Connecting the dots on fibroblast growth factor 23 and left ventricular hypertrophy
OM Gutiérrez
Nephrology Dialysis Transplantation 2016
Arrhythmia and Sudden Death in Hemodialysis Patients: Protocol and Baseline Characteristics of the Monitoring in Dialysis Study
DM Charytan, R Foley, PA McCullough, JD Rogers, P Zimetbaum, CA Herzog, JA Tumlin
Clinical journal of the American Society of Nephrology : CJASN 2016
Fibroblast growth factor-23 but not sKlotho levels are related to diastolic dysfunction in type 1 diabetic patients with early diabetic nephropathy
B Dogan, IH Arikan, D Guler, N Keles, B Isbilen, F Isman, A Oguz
International Urology and Nephrology 2016
Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study
R Mehta, X Cai, J Lee, JJ Scialla, N Bansal, JH Sondheimer, J Chen, LL Hamm, AC Ricardo, SD Navaneethan, R Deo, M Rahman, HI Feldman, AS Go, T Isakova, M Wolf
JAMA Cardiology 2016
Association between FGF23, α-Klotho, and Cardiac Abnormalities among Patients with Various Chronic Kidney Disease Stages
S Tanaka, S Fujita, S Kizawa, H Morita, N Ishizaka, T Shimosawa
PloS one 2016
Efficacy and safety of iron isomaltoside (Monofer®) in the management of patients with iron deficiency anemia
PP Kalra, S Bhandari
International journal of nephrology and renovascular disease 2016
Bone and Mineral Metabolism: Where Are We, Where Are We Going, and How Will We Get There?
HM Kronenberg
The Journal of clinical endocrinology and metabolism 2016
Central blood pressure and chronic kidney disease
Y Ohno
World Journal of Nephrology 2016
Cardiovascular Effects of Unilateral Nephrectomy in Living Kidney Donors
WE Moody, CJ Ferro, NC Edwards, CD Chue, EL Lin, RJ Taylor, P Cockwell, RP Steeds, JN Townend
Hypertension 2016
Phosphate Binding Therapy to Lower Serum Fibroblast-Growth-Factor-23 Concentrations in Chronic Kidney Disease: Rationale and Study Design of the Sevelamer on FGF23 Trial (SoFT)
AY Adema, MA de Jong, MH de Borst, PM Wee, MG Vervloet
Nephron. Clinical practice 2016
FGF-23 and cardiovascular disease: review of literature
J Batra, RS Buttar, P Kaur, J Kreimerman, ML Melamed
Current opinion in endocrinology, diabetes, and obesity 2016
Associations of Conventional Echocardiographic Measures with Incident Heart Failure and Mortality: The Chronic Renal Insufficiency Cohort
RF Dubin, R Deo, N Bansal, AH Anderson, P Yang, AS Go, M Keane, R Townsend, A Porter, M Budoff, S Malik, J He, M Rahman, J Wright, T Cappola, R Kallem, J Roy, D Sha, MG Shlipak
Clinical journal of the American Society of Nephrology : CJASN 2016
The role of phosphate in kidney disease
MG Vervloet, S Sezer, ZA Massy, L Johansson, M Cozzolino, D Fouque
Nature Reviews Nephrology 2016
Longitudinal assessment of cardiac morphology and function following kidney transplantation
C Kensinger, A Hernandez, A Bian, M Fairchild, G Chen, L Lipworth, TA Ikizler, KA Birdwell
Clinical Transplantation 2016
Response of fibroblast growth factor 23 to volume interventions in arterial hypertension and diabetic nephropathy:
JK Humalda, S Seiler-Muler, AJ Kwakernaak, MG Vervloet, G Navis, D Fliser, GH Heine, MH de Borst
Medicine 2016
Association of serum intact fibroblast growth factor 23 with left ventricular mass and different echocardiographic findings in patients on hemodialysis
AA Nassiri, MS Hakemi, R Safar-Pour, A Ahmadi, M Tohidi, BS Kashani, F Esfehani, S Alatab
Journal of Translational Internal Medicine 2016
Carboxy-terminal fragment of fibroblast growth factor 23 induces heart hypertrophy in sickle cell disease
M Courbebaisse, H Mehel, C Petit-Hoang, JA Ribeil, L Sabbah, V Tuloup-Minguez, D Bergerat, JB Arlet, A Stanislas, JC Souberbielle, HL Clésiau, R Fischmeister, G Friedlander, D Prié
Haematologica 2016
Fibroblast growth factor 23 dysregulates late sodium current and calcium homeostasis with enhanced arrhythmogenesis in pulmonary vein cardiomyocytes
SY Huang, YC Chen, YH Kao, MH Hsieh, YK Lin, CC Chung, TI Lee, WC Tsai, SA Chen, YJ Chen
Oncotarget 2016
FGF23 promotes myocardial fibrosis in mice through activation of β-catenin
H Hao, X Li, Q Li, H Lin, Z Chen, J Xie, W Xuan, W Liao, J Bin, X Huang, M Kitakaze, Y Liao
Oncotarget 2016

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Blogged by 1
Posted by 8 X users
Referenced in 17 patents
Referenced in 6 Wikipedia pages
Highlighted by 1 platforms
Referenced in 1 clinical guideline sources
649 readers on Mendeley
1 readers on CiteULike
See more details